Completed PHASE1 INTERVENTIONAL 2-arm NCT03310047

Intra-individual Reproducibility in Nerve Block Duration

Sponsor: Innovation Fund Denmark

Interventions Infusion, Lidocaine, 0.5%, 10 mL Infusion, Lidocaine, 0.5%, 5 mL

Updated 6 times since 2017 Last updated: May 13, 2018 Started: Oct 30, 2017 Primary completion: Mar 1, 2018 Completion: Mar 1, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Anesthesia, Regional and is currently completed. Innovation Fund Denmark leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1

Status: Recruiting → Completed
Jan 2018 — Jun 2018 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Oct 2017 — Jan 2018 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Innovation Fund Denmark
Nordsjaellands Hospital

Data source: Nordsjaellands Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hillerød, Denmark